New Approach in the Study of the Autonomic Nervous System Through Cardiac Variability in Sleep Apnea Syndrome.

ConditionSleep Apnea
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-64
SponsorUniversity Hospital, Lille

About this trial

The main objective of this study is to compare the different variations of the cardiac variability index measured thanks to the technique developed by the CIC-IT between subjects with severe SAS and healthy subjects with sleep pathology.

In a first step, these two groups will be compared in REM sleep phase because it is the period during which the risk of sleep apnea syndrome is the highest. In a second step, the same methodology will be applied for the other sleep phases and correlations will be established with the other markers of cardiac variability (HRV) already known. This will allow to validate a reliable method of screening for SAS that is more accessible in ambulatory settings by means of a machine learning system based on artificial intelligence

Eligibility criteria

Qualifiers

Group healthy subjects - 1): absence of sleep disorder referenced in the ICSD-3.

Epworth Sleep Scale < 11

Pittsburgh Quality Sleep Index < 6

Berlin Questionnaire: < 2 positive categories

Disqualifiers

Cardiac rhythm disorder

Neurological or psychiatric pathology impacting on ANS

Control group (healthy subjects - 1)

Complaint of sleep disorder

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

97 Participants
are grouped into 2 trial groups

Sponsors and collaborators